Brevan Howard Capital Management’s Eli Lilly LLY Stock Holding History

Brevan Howard Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.7M	Sell	17,119 -1,443	-8%	-$1.46M	0.14%	90
2025 Q4	$20M	Sell	18,562 -1,999	-10%	-$1.91M	0.22%	71
2025 Q3	$15.7M	Buy	20,561 +385	+2%	+$287K	0.07%	85
2025 Q2	$15.7M	Buy	20,176 +18,718	+1,284%	+$14.5M	0.09%	112
2025 Q1	$1.2M	Sell	1,458 -21,977	-94%	-$18.3M	0.01%	432
2024 Q4	$18.1M	Sell	23,435 -7,340	-24%	-$6.08M	0.12%	38
2024 Q3	$27.3M	Buy	30,775 +30,213	+5,376%	+$27.2M	0.19%	35
2024 Q2	$509K	Buy	+562	New	+$450K	﹤0.01%	599
2024 Q1	–	Sell	-4,042	Closed	-$2.36M	–	1191
2023 Q4	$2.36M	Buy	+4,042	New	+$2.36M	0.03%	104

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Brevan Howard Capital Management's LLY Position: Q1 2026 in Review

Brevan Howard Capital Management reduced its Eli Lilly (LLY) stake by 7.8% in Q1 2026, selling an estimated $1.46M and leaving 17,119 shares worth $15.7M. The position accounts for 0.14% of the portfolio, ranked #90.

Brevan Howard Capital Management first reported a position in LLY in Q4 2023 and has held it in 9 quarters since. The position peaked at $27.3M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Brevan Howard Capital Management held 17,119 shares of Eli Lilly worth $15.7M as of Q1 2026.
Brevan Howard Capital Management sold 1,443 Eli Lilly shares in Q1 2026, an estimated $1.46M.
Eli Lilly made up 0.14% of Brevan Howard Capital Management's portfolio in Q1 2026, its #90 holding.
Brevan Howard Capital Management first reported a position in Eli Lilly in Q4 2023 and has held it in 9 quarters since.
Brevan Howard Capital Management's Eli Lilly position peaked at $27.3M in Q3 2024.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.